Sphere Fluidics closes $40m funding round
Sphere Fluidics, a UK company that has developed and is commercializing single cell analysis systems underpinned by its picodroplet technology, has just closed a US$40m investment round.
Stay updated with breaking news from Cell Line Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sphere Fluidics, a UK company that has developed and is commercializing single cell analysis systems underpinned by its picodroplet technology, has just closed a US$40m investment round.
Gain insights on topics from immunotyping, cell sorting, quality control and more
Dublin, Oct. 13, 2021 (GLOBE NEWSWIRE) -- The "Global Protein Expression Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
Gain insights on topics from immunotyping, cell sorting, quality control and more
Gain insights on topics from antibody performance, cell line development, method validation and more